Blockchain Registration Transaction Record
Biotech Company Glafabra Therapeutics Collaborates with University of Utah for Fabry Disease Clinical Investigation
Glafabra Therapeutics partners with University of Utah for groundbreaking Fabry disease clinical investigation. Collaboration aims to advance development of new treatment for rare genetic disorder, addressing unmet medical need.

This news highlights a significant collaboration between a leading biotechnology company and a renowned research institution to advance the development of a new treatment for a rare genetic disorder. The partnership has the potential to bring innovative therapies to patients suffering from Fabry disease, addressing an unmet medical need in the field of rare diseases.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x4dc9924f9818e7694cc9adc2e2dc2d4e774d009f323b0fd5693184f5c2afe776 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | jazzu6ga-750195bbb33dba6c350b959d3ab24596 |